SEARCH

SEARCH BY CITATION

References

  • 1
    Edwards FC. Truelove Sc. The course and prognosis of ulcerative colitis: part 1: short-term prognosis. Gut. 1963; 4: 300308.
  • 2
    Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985; 89: 10051013.
  • 3
    Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. New Eng J Med. 1994; 330: 18411851.
  • 4
    D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporin versus intravenous corticosteroids as a single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001; 120: 13231329.
  • 5
    Feutren G, Mihatsch MJ. Risk factors for cyclosporin-induced nephropathy in patients with auto-immune diseases. International Kidney biopsy registry of Cyclosporin in Autoimmune Diseases N Eng J Med. 1992; 326: 16541660.
  • 6
    D'Haens G, Bourgeois S, Hiele M, et al. Two and four milligram of intravenous cyclosporin are equally effective in severe attacks of ulcerative colitis. Gastroenterology 2000;A4198.
  • 7
    Actis GC, Aimo G, Priolo G. et al. Efficacy and efficiency of oral micro emulsion cyclosporin versus intravenous and soft gelatine capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis. 1998; 4: 276279.
  • 8
    Karagiannis JA, Paraskeva KD. Oral azathioprine and low-dose oral cyclosporin are equally effective and safe in maintenance of the response in patients with acute ulcerative colitis who responded to intravenous cyclosporin. Gut. 2001; 49: A2085.
  • 9
    Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Disease. 1999; 5: 110.
  • 10
    Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996; 38: 905910.
  • 11
    Kornbluth A, Lichtiger S, Present S, et al. Long-term results of oral cyclosporin in patients with severe ulcerative colitis: a double-bind, randomized, multicenter trial. Gastroenterology. 1994; 106: A714.
  • 12
    Lichtiger S. Cyclopsorin therapy in inflammatory bowel disease: open-label experience. Mt Sinai J Med. 1990; 57: 315319.
  • 13
    Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J. Gastroenterology. 1999; 94: 15871592.
    Direct Link:
  • 14
    Actis GC, Ottobrelli A, Pera A, et al. Continuously infused cyclosporin at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastrolenterol. 1993; 17: 1013.
  • 15
    Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with CSA for severe acute ulcerative colitis. Aliment Pharmacol Ther. 1998; 12: 973978.
  • 16
    Carbonnel F, Boruchowitz A, Duclos B, et al. Intravenous cyclosporin in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci. 1996; 41: 24712476.
  • 17
    Suryakanth RG, Griffel LH, Gialanella RJ, et al. Cyclosporin therapy in inflammatory bowel disease. J Clin. Gastroenterol. 1999; 29: 151154.
  • 18
    Wenzl HH, Petritsch W, Aichbichler BW, et al. Short-term efficacy and long-term outcome of CSA treatment in patients with severe ulcerative colitis. Z Gastroenterol. 1998; 36: 287293.
  • 19
    Van Gossum A, Schmit A, Adler M, et al. Short- and long-term efficacy of cyclosporin administration in patients with acute and severe ulcerative colitis. Acta Gastroenterol Belg. 1997; 60: 197200.
  • 20
    Fernandez-Banares F, Bertran X, Esteve-Comas M, et al. Azathioprine is useful in maintaining long-term remission induced by intravenous CSA in steroid-refractory severe ulcerative colitis. Am J Gastroenterol. 1996; 91: 24982499.
  • 21
    Ramakrishna J, Langhans N, Calenda K, et al. Combined use of CSA and azathioprine or 6-Mercaptopurine in Paediatric inflammatory bowel disease. J Ped Gastroenterol. 1996; 22: 296302.
  • 22
    Svanoni F, Bonassi U, Bagnolo F, et al. Effectiveness of CSA A in the treatment of acute refractory ulcerative colitis. Gastroenterology. 1998; 114: A1096.
  • 23
    Hyde GM, Thillainayagam AV, Jewell DP. Intravenous CSA as a rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol. 1998; 10: 411413.
  • 24
    Rowe FA, Walker JH, Karp LC, et al. Factors predictive of response to CSA treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol. 2000; 95: 20002008.
    Direct Link:
  • 25
    Rosselli M, Casa A, Orlando A, et al. Low dosage of intravenous CSA in the treatment of sever ulcerative colitis. Gut. 2000; 47 (suppl 3): A241.